Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic Cancer

Clinical trial NCT00813163 · COMPLETED

Trial details

NCT number: NCT00813163
Sponsor: PharmaEngine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Neoplasms

Start date: 2009-01-01
Primary completion: 2010-12-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.